Wird geladen...
Simplified steps to heterologous prime-boost HIV vaccine development?
The RV 144 HIV vaccine efficacy study showed a reduction in HIV-1 infection risk in Thai volunteers who received two priming vaccinations of vCP1521 ALVAC (attenuated recombinant canarypox virus expressing HIV group–specific antigen, polymerase, and envelope genes) followed by two additional ALVAC v...
Gespeichert in:
| Veröffentlicht in: | J Clin Invest |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819123/ https://ncbi.nlm.nih.gov/pubmed/31566582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI132440 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|